Is Depression a Chemical Imbalance: Separating Neuroscience from Myth

Key Takeaways:

• Do not stop your medication because of anything you read here. Stopping abruptly causes discontinuation symptoms and raises relapse risk. Any change goes through your prescriber.
• The simple serotonin story didn’t hold up. A 2022 umbrella review found no consistent evidence that depression is caused by lowered serotonin activity or concentration.
• That review was itself heavily contested. Thirty-six researchers published a critique in the same journal arguing it made fundamental errors and presented no new analyses.
• Mechanism and effectiveness are separate questions. Whether we understand how a drug works and whether it works are two different investigations, and the second one has answers.
• Nobody serious claims it’s one chemical. Depression involves genetics, stress, inflammation, neuroplasticity, and circumstances. The imbalance line was always shorthand.

You’ve been told your depression is a chemical imbalance. Then you saw a headline saying that’s been debunked, and now you’re wondering whether the medication in your cabinet is doing anything at all.

Before anything else: don’t stop taking it based on a headline or on this article. Discontinuation needs planning with whoever prescribed it.

Now let’s look at what the science actually says, including the argument still going on inside the field.

Is Depression Really a Chemical Imbalance in the Brain?

So, is depression a chemical imbalance? Not in the way the phrase implies. The longer answer is more interesting, and it’s where the useful information lives.

Is depression a chemical imbalance in any literal sense? The line was never a scientific claim so much as shorthand for explaining medication in one sentence. It did some good, since framing depression as biological reduced blame. It also oversimplified something nobody ever thought was simple.

The Serotonin Hypothesis and What Research Actually Shows

In 2022, Joanna Moncrieff and colleagues published an umbrella review in Molecular Psychiatry examining six areas of serotonin research. Their conclusion: no consistent evidence of an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations.

The gene findings were the most striking part. Two large, high-quality studies — one genetic association study of 115,257 people and a collaborative meta-analysis of 43,165 — found no evidence of a link between the serotonin transporter gene and depression, or of any interaction between that gene, stress, and depression.

How Brain Chemistry Influences Depression Symptoms

Here’s the part the headlines skipped. Thirty-six researchers published a systematic critique in the same journal arguing the review presented no new analyzes of the data, applied its own criteria for research quality, interpreted findings differently from the original studies, and made fundamental errors.

They also made a point worth holding onto: the serotonin theory was never proposed to mean people get depressed because one chemical is out of balance. It described brain changes present in depression that might explain how some antidepressants work. Different claim entirely.

So brain chemistry is involved. What’s dead is the idea that it’s one chemical, running low, in everybody.

Neurotransmitters Beyond Serotonin

Depression is heterogeneous — genetically, clinically, pharmacologically — which is the single most important thing to understand about it. Two people with identical depression symptoms can have quite different biology underneath, and that’s not a gap in the research so much as the finding itself.

Serotonin appears to matter for a subgroup. Other systems are implicated too — glutamate, GABA, acetylcholine — and mechanisms well outside neurotransmission are now central to the research, including neuroinflammation, HPA axis dysregulation, and neuroplasticity.

The Role of Dopamine and Norepinephrine in Mood Regulation

This is where the subgroup picture gets practical. Presentations dominated by anhedonia, low energy, and slowed thinking appear more connected to dopamine and noradrenaline than to serotonin.

Which may explain a clinical observation prescribers make constantly — that some patients respond poorly to an SSRI and considerably better to a dual-action antidepressant. Same diagnosis, different biology, different drug.

Depression Causes: Separating Biology From Environment

Depression causes don’t sort into two columns, which is the problem with the way that question is usually asked.

Chronic stress changes cortisol regulation and hippocampal function. Poverty and loneliness produce measurable physiological effects. Genetic vulnerability only matters given certain environments. Asking which one caused your depression is like asking whether a fire was caused by the match or the gasoline.

The Antidepressant Debate: Do They Target Chemical Imbalances?

Here’s the distinction that resolves most of the confusion, and one that Moncrieff’s critics pressed hard. Mechanism and effectiveness are separate questions.

A 2018 network meta-analysis of 522 trials covering 116,477 patients found all 21 antidepressants studied more efficacious than placebo for adults with major depression. Researchers debate the size of that advantage. Its existence is well supported.

Aspirin was in use for roughly seventy years before anyone worked out how it worked. Not understanding a mechanism has never meant a treatment doesn’t — and I’d want anyone reconsidering their medication to sit with that for a moment.

How Modern Medications Affect Neurotransmitter Function

What SSRIs do immediately is block serotonin reuptake, and that happens within hours. What they don’t do is improve mood within hours — that takes four to six weeks.

That gap is the strongest argument against the simple model, and it’s why research has moved downstream. Current thinking focuses on what the receptor change sets off over the following weeks: BDNF, synaptic plasticity, the brain’s capacity to form new connections. Some evidence suggests antidepressants act on neurotrophin receptors more directly than anyone assumed.

Psychological Factors That Shape Mental Health Outcomes

Psychological factors aren’t a lesser category of cause. Rumination, self-criticism, avoidance, and learned helplessness all predict onset and maintenance, and all respond to treatment.

Which is why psychotherapy works, and why it works through the brain like everything else. Talking changes neural function — that isn’t a metaphor, and it’s not a softer alternative to biology.

Why the Chemical Imbalance Theory Remains Controversial

Because two things are being argued about at once, and they keep getting conflated.

Notice you can answer no to the first and yes to the third without contradicting yourself. Most public argument about this collapses those rows into one.

What Neuroscience Currently Reveals About Depression

No brain scan diagnoses depression. No blood test either. Imaging studies find group-level differences — hippocampal volume, amygdala reactivity, connectivity patterns — that don’t translate into an individual diagnostic.

Where the field has moved is toward networks and plasticity instead of single molecules, and toward accepting that depression is probably several conditions wearing one name.

Getting Effective Mental Health Treatment at Shine Mental Health

So does asking if depression is a chemical imbalance change anything about your mental health treatment? Less than the headlines implied.

Antidepressants still help many people. Therapy still helps many people. Combining them still outperforms either alone for moderate to severe depression. What’s changed is that nobody should be handed a confident story about their neurotransmitters (an improvement in honesty, not a loss of treatment).

At Shine Mental Health, clinicians assess what’s actually driving your symptoms, rule out medical contributors, and build a plan combining therapy and medication where that fits. If you’re considering stopping an antidepressant, bring it to a prescriber instead of doing it alone. If you’re having thoughts of harming yourself, call or text 988 now.

FAQs

1. Can antidepressants work if depression isn’t caused by a chemical imbalance?

Yes, and this is the central point. Effectiveness is established through randomized trials comparing drug against placebo, which doesn’t depend on any theory of cause. A 2018 analysis of 522 trials and 116,477 patients found all antidepressants studied outperformed placebo. Plenty of medicines worked for decades before anyone explained why.

2. Which neurotransmitters matter most for depression beyond just serotonin levels?

Dopamine and noradrenaline appear especially relevant where anhedonia, low energy, and slowed thinking dominate, which may be why some people respond better to dual-action antidepressants. Glutamate has become central — ketamine acts there. GABA and acetylcholine are implicated too.

3. How do genetic factors and life stress combine to trigger depression?

Through interaction, which is why neither alone explains much. Heritability estimates for depression run around a third, meaning genes load the situation without determining it. Notably, the serotonin transporter gene-by-stress interaction that dominated this literature for years failed to replicate in the largest studies, so the specifics are less settled than textbooks once implied.

4. Why do some people respond to mental health treatment while others don’t?

Largely because depression is heterogeneous — probably several distinct conditions sharing a name and a symptom list. Roughly a third of patients achieve full remission on a first antidepressant, which reflects biological variation between people, not anyone failing.

5. What do brain imaging studies reveal about the chemical imbalance theory in depression?

The picture is more complicated than a single chemical running low. Imaging finds differences at group level in hippocampal volume, amygdala reactivity, and network connectivity, and some of these normalize with treatment. But no scan can diagnose an individual, and findings vary considerably between studies.

References

• Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular Psychiatry. https://www.nature.com/articles/s41380-022-01661-0
• Jauhar, S., Arnone, D., Baldwin, D. S., et al. (2023). A leaky umbrella has little value: Evidence clearly indicates the serotonin system is implicated in depression. Molecular Psychiatry. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618084/